Literature DB >> 30618304

BCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes.

Nour Abuhadra1, Sudipto Mukherjee1, Karam Al-Issa1, Vera Adema2, Cassandra M Hirsch2, Anjali Advani1, Bartlomiej Przychodzen2, Ahed Makhoul1, Hassan Awada2, Jaroslaw P Maciejewski2, Mikkael A Sekeres1, Aziz Nazha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30618304      PMCID： PMC8694070          DOI： 10.1080/10428194.2018.1543885

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

Review 1.  Myelodysplastic syndromes.

Authors:  Ayalew Tefferi; James W Vardiman
Journal:  N Engl J Med       Date:  2009-11-05       Impact factor: 91.245

2.  Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

Authors:  D A Sallman; R Komrokji; C Vaupel; T Cluzeau; S M Geyer; K L McGraw; N H Al Ali; J Lancet; M J McGinniss; S Nahas; A E Smith; A Kulasekararaj; G Mufti; A List; J Hall; E Padron
Journal:  Leukemia       Date:  2015-10-30       Impact factor: 11.528

3.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

4.  Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.

Authors:  A Nazha; K Al-Issa; B K Hamilton; T Radivoyevitch; A T Gerds; S Mukherjee; V Adema; A Zarzour; N Abuhadra; B J Patel; C M Hirsch; A Advani; B Przychodzen; H E Carraway; J P Maciejewski; M A Sekeres
Journal:  Leukemia       Date:  2017-08-18       Impact factor: 11.528

5.  BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

Authors:  Frederik Damm; Virginie Chesnais; Yasunobu Nagata; Kenichi Yoshida; Laurianne Scourzic; Yusuke Okuno; Raphael Itzykson; Masashi Sanada; Yuichi Shiraishi; Véronique Gelsi-Boyer; Aline Renneville; Satoru Miyano; Hiraku Mori; Lee-Yung Shih; Sophie Park; François Dreyfus; Agnes Guerci-Bresler; Eric Solary; Christian Rose; Stéphane Cheze; Thomas Prébet; Norbert Vey; Marion Legentil; Yannis Duffourd; Stéphane de Botton; Claude Preudhomme; Daniel Birnbaum; Olivier A Bernard; Seishi Ogawa; Michaela Fontenay; Olivier Kosmider
Journal:  Blood       Date:  2013-09-18       Impact factor: 22.113

Review 6.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

7.  Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.

Authors:  A Nazha; M Narkhede; T Radivoyevitch; D J Seastone; B J Patel; A T Gerds; S Mukherjee; M Kalaycio; A Advani; B Przychodzen; H E Carraway; J P Maciejewski; M A Sekeres
Journal:  Leukemia       Date:  2016-05-20       Impact factor: 11.528

8.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
  8 in total
  7 in total

Review 1.  BCOR gene alterations in hematologic diseases.

Authors:  Paolo Sportoletti; Daniele Sorcini; Brunangelo Falini
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

2.  Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.

Authors:  Jan-Niklas Eckardt; Sebastian Stasik; Michael Kramer; Christoph Röllig; Alwin Krämer; Sebastian Scholl; Andreas Hochhaus; Martina Crysandt; Tim H Brümmendorf; Ralph Naumann; Björn Steffen; Volker Kunzmann; Hermann Einsele; Markus Schaich; Andreas Burchert; Andreas Neubauer; Kerstin Schäfer-Eckart; Christoph Schliemann; Stefan W Krause; Regina Herbst; Mathias Hänel; Norbert Frickhofen; Richard Noppeney; Ulrich Kaiser; Claudia D Baldus; Martin Kaufmann; Zdenek Rácil; Uwe Platzbecker; Wolfgang E Berdel; Jiří Mayer; Hubert Serve; Carsten Müller-Tidow; Gerhard Ehninger; Friedrich Stölzel; Frank Kroschinsky; Johannes Schetelig; Martin Bornhäuser; Christian Thiede; Jan Moritz Middeke
Journal:  Cancers (Basel)       Date:  2021-04-26       Impact factor: 6.639

Review 3.  The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications.

Authors:  Hassan Awada; Bicky Thapa; Valeria Visconte
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

4.  Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication.

Authors:  Abdulla Watad; Mark Kacar; Nicola Luigi Bragazzi; Qiao Zhou; Miriam Jassam; Jan Taylor; Eve Roman; Alexandra Smith; Richard A Jones; Howard Amital; Catherine Cargo; Dennis McGonagle; Sinisa Savic
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

5.  Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.

Authors:  Xiao Li; Feng Xu; Zheng Zhang; Juan Guo; Qi He; Lu-Xi Song; Dong Wu; Li-Yu Zhou; Ji-Ying Su; Chao Xiao; Chun-Kang Chang; Ling-Yun Wu
Journal:  Clin Epigenetics       Date:  2021-08-30       Impact factor: 6.551

Review 6.  Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.

Authors:  Hussein Awada; Carmelo Gurnari; Arda Durmaz; Hassan Awada; Simona Pagliuca; Valeria Visconte
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

Review 7.  Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration.

Authors:  Tzu-Hua Chen-Liang
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.